GLP-1RA Obesity Trials Show Mixed Results as Pharma Races to Redefine Weight Loss Therapies 1 year ago JohnIn Biopharma HighlightsBreaking NewsTop Stories
Fluorescence-Guided Surgery Advances Tumor Detection in Clinical Trials 1 year ago JohnIn Breaking NewsBreakthroughsClinical TrialsResearch Updates
Pancreatic Tumors Evade Immune Detection by Rewiring Retrotransposon Activity 1 year ago JohnIn Featured AnalysisResearch UpdatesTop Stories
Lenacapavir’s Landmark Trial Results Reshape HIV Prevention Landscape 1 year ago JohnIn Breaking NewsPharma Industry Updates
BIO Clinical Trial Diversity Summit Unveils National Center for Health Disparities at Howard University 1 year ago JohnIn Research UpdatesTop Stories
FDA Approves Vepdegestrant, First Oral PROTAC Targeting Estrogen Receptor in Breast Cancer 1 year ago JohnIn Clinical TrialsFDA ApprovalsResearch Updates
AI-Driven ECG Technologies Gain Ground as CMS Approves Reimbursement Pathways 1 year ago JohnIn AI & DataBreakthroughsClinical Trials
Inebilizumab Shows Promise in Treating Rare Autoimmune Disease: Phase 3 Trial Results 1 year ago JohnIn AI & DataPharma Industry UpdatesResearch Updates
PDS Biotech Advances HPV-Targeted Immunotherapy with Updated Phase 3 Trial Design and Promising Clinical Data 1 year ago JohnIn Biopharma HighlightsFDA ApprovalsResearch Updates
FDA Approves Breakthrough Gene Therapy for Rare Pediatric Disorder; Advances in Immune Therapeutics and NIH Workshop Spotlight 1 year ago JohnIn Breaking NewsClinical TrialsFDA Approvals
Ocugen’s Retinal Gene Therapy Trials Show Encouraging Progress at NYC Clinical Showcase 1 year ago JohnIn BreakthroughsClinical Trials
AbbVie’s Emraclidine Falls Short in Phase 2 Schizophrenia Trials, But Safety Profile Encourages Future Exploration 1 year ago JohnIn Pharma Industry UpdatesTop Stories
Outlook Therapeutics Cuts Workforce After Wet AMD Trial Misses FDA Benchmark 1 year ago JohnIn People
Novo Nordisk Surges Ahead in Obesity Pill Race as Lilly Stumbles in Pivotal Trial 1 year ago JohnIn BreakthroughsPharma Industry UpdatesTop Stories
Akero Therapeutics Advances Phase 3 Trials for MASH Drug EFX 1 year ago JohnIn Clinical TrialsResearch Updates
